Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    NIEMANN-PICK DISEASE, TYPE C2
Show Display Options
Rank Status Study
1 Unknown  Serum Biomarker HE4 During IVF Treatment
Conditions: IVF Treatment;   Human Epididymal Secretory Protein E4
Intervention:
2 Recruiting Arimoclomol Prospective Study in Patients Diagnosed With NiemannPick Disease Type C
Condition: Niemann-Pick Disease, Type C
Interventions: Drug: arimoclomol;   Drug: Placebo
3 Recruiting A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
Condition: Niemann-Pick Disease, Type C
Intervention:

Indicates status has not been verified in more than two years